Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2025 18:57 ET | Source: Robbins LLP

Robbins LLP Reminds ZBIO Stockholders with Large Losses to Contact the Law Firm for Information on Leading the Zenas BioPharma, Inc. Class Action

Robbins LLP is Investigating Allegations that Zenas BioPharma, Inc. (ZBIO) Misled Investors in Connection with its IPO
April 21, 2025 17:37 ET | Source: Robbins LLP

Zenas BioPharma, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against ZBIO

Robbins LLP is Investigating Allegations that Zenas BioPharma, Inc. (ZBIO) Misled Investors in Connection with its IPO
March 31, 2025 14:03 ET | Source: Robbins LLP

GERN Stockholders Should Contact Robbins LLP for Information About How They Can Lead the Geron Corporation Class Action

Robbins LLP is Investigating Allegations that Geron Corporation (GERN) Misled Investors Regarding the Launch and Potential Growth of Rytelo
February 18, 2025 21:17 ET | Source: Robbins LLP

BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. Investors of the Pending Lead Plaintiff Deadline – March 10, 2025

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
January 17, 2025 17:29 ET | Source: Robbins LLP

BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
January 13, 2025 20:42 ET | Source: Robbins LLP

Caribou Biosciences, Inc. Shareholders are Encouraged to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the CRBU Class Action

Robbins LLP is Investigating Allegations that Caribou Biosciences, Inc. (CRBU) Misled Investors Regarding the Efficacy of its Lead Drug Candidate
January 13, 2025 20:39 ET | Source: Robbins LLP

BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against BioAge Labs, Inc.

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO
January 13, 2025 19:49 ET | Source: Robbins LLP

AZN Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the AstraZeneca PLC Class Action

Robbins LLP is Investigating Allegations that AstraZeneca PLC (AZN) Misled Investors Regarding its Legal Exposure in China
January 06, 2025 19:08 ET | Source: Robbins LLP

APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.

Robbins LLP is Investigating Allegations that Applied Therapeutics, Inc. (APLT) Misled Investors Regarding its Lead Drug Candidate
January 02, 2025 15:26 ET | Source: Robbins LLP

Robbins LLP Reminds Investors of the Applied Therapeutics, Inc. (APLT) Class Action and Urges Investors with Large Losses to Contact the Firm for Information

Robbins LLP is Investigating Allegations that Applied Therapeutics, Inc. (APLT) Misled Investors Regarding its Lead Drug Candidate

Next Page keyboard_arrow_right